LABORATOIRES SYNTH-INNOVE
LABORATOIRES SYNTH-INNOVE (France) holds 1 active US FDA Type II Drug Master File. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “LABORATOIRES SYNTH-INNOVE: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/laboratoires-synth-innove
Overview
LABORATOIRES SYNTH-INNOVE is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering BM105.
API / Drug Master Files
LABORATOIRES SYNTH-INNOVE holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- BM105Active2018-04-16
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to LABORATOIRES SYNTH-INNOVE in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this LABORATOIRES SYNTH-INNOVE?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.